Answers are grounded in this paper and cite their sources.
Spinal metastasis is a serious issue in spine care that can have a negative impact on a patient’s quality of life by causing pain, neurological deficits, and ambulation issues. It affects approximately 20%–50% of cancer patients, with a higher prevalence in lung and breast cancer. 1,2 The risk of spine metastases increases with age, time since diagnosis, and the number of comorbidities. Patients with spine metastases usually present with pain, spinal insta-bility, and nerve function deficit, which can impact their quality of life. 1,3 Spine metastases can be detected using various diagnostic methods, including computed tomography (CT), magnetic resonance imaging, bone scintigraphy, and positron emission tomography. 2,3 The progression of spine metastases involves transportation from the primary tumor, arrest within the spine, and growth of cancer cells. 3 Metastasis occurs more frequently in the tho-racic and lumbar spine compared to the cervical spine, making the spine the third most com-mon site for metastasis of malignant neoplasm. 4 Spinal cord compression, which may affect up to 15% of individuals with metastatic neoplastic malignancies, 3 can lead to myelopathy or radiculopathy, and in severe cases, debilitating and potentially fatal myelopathy. Early diagnosis and treatment are crucial in such cases. 4 A modified Tomita score of 6 to 8 points indicates the need for radiation therapy or palliative surgery, and can also help predict a patient’s survival and response
No takes yet. Share an insight, caveat, or question.
Liawrungrueang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: